Influenza virus-infected host cell surface

The influenza virus-infected host cell surface is a dynamic interface where viral proteins are expressed following the hijacking of host cellular machinery. Key viral proteins localized to this surface include Hemagglutinin (HA), Neuraminidase (NA), and the Matrix 2 (M2) ion channel, which are essential for the assembly and budding of new virions (Source: NIH, Influenza Virus: Structure and Replication). This surface serves as a primary target for the host immune system, which recognizes these viral antigens to initiate clearance through mechanisms like antibody-dependent cellular cytotoxicity (ADCC) (Source: Nature Communications, PMID: 28834719). In the context of disease, the density and composition of these proteins on the cell surface determine the efficiency of viral spread and the severity of the infection (Source: Journal of Virology, PMID: 21123387). Therapeutic interventions often target this surface; for instance, neuraminidase inhibitors like Oseltamivir prevent the cleavage of sialic acid, thereby trapping new virions on the cell surface and preventing further infection (Source: StatPearls, Antiviral Medications). Additionally, experimental therapies such as broadly neutralizing antibodies and CAR-T cells are being developed to target conserved regions of surface-expressed proteins to provide broader protection against various influenza strains (Source: PubMed, PMID: 30639163). The surface also plays a role in viral evasion, as the virus can modulate the expression of these proteins to avoid detection by the host's innate and adaptive immune responses. Understanding the molecular landscape of the infected cell surface is crucial for the design of next-generation vaccines and antivirals that can overcome the challenges of antigenic drift.

Other names

Infected cell membraneInfluenza-infected cell surfaceViral antigen-presenting host cellInfluenza virus-infected cell surface

Inhibition of viral neuraminidase to prevent progeny release, blockade of M2 ion channels to prevent viral uncoating, and induction of antibody-dependent cellular cytotoxicity (ADCC) or phagocytosis (ADCP) by monoclonal antibodies targeting surface-expressed viral antigens.